Target Price | $39.00 |
Price | $26.31 |
Potential |
48.23%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target OrthoPediatrics Corp. 2026 .
The average OrthoPediatrics Corp. target price is $39.00.
This is
48.23%
register free of charge
$50.00
90.04%
register free of charge
$26.00
1.18%
register free of charge
|
|
A rating was issued by 6 analysts: 5 Analysts recommend OrthoPediatrics Corp. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the OrthoPediatrics Corp. stock has an average upside potential 2026 of
48.23%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 204.73 | 238.74 |
37.65% | 16.61% | |
EBITDA Margin | -5.26% | 6.63% |
6.72% | 226.15% | |
Net Margin | -19.40% | -12.99% |
28.11% | 33.05% |
6 Analysts have issued a sales forecast OrthoPediatrics Corp. 2025 . The average OrthoPediatrics Corp. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an OrthoPediatrics Corp. EBITDA forecast 2025. The average OrthoPediatrics Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 OrthoPediatrics Corp. Analysts have issued a net profit forecast 2025. The average OrthoPediatrics Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.64 | -1.28 |
76.34% | 21.95% | |
P/E | negative | |
EV/Sales | 2.73 |
4 Analysts have issued a OrthoPediatrics Corp. forecast for earnings per share. The average OrthoPediatrics Corp. EPS is
This results in the following potential growth metrics and future valuations:
OrthoPediatrics Corp....
Analyst | Rating | Action | Date |
---|---|---|---|
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
Needham |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
Needham |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
Needham |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Oct 14 2024 |
Analyst Rating | Date |
---|---|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 21 2025 |
Locked
Needham:
Locked
➜
Locked
|
Mar 05 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Mar 05 2025 |
Locked
Needham:
Locked
➜
Locked
|
Jan 14 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Dec 18 2024 |
Locked
Needham:
Locked
➜
Locked
|
Nov 08 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 14 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.